ZIPEXOLE pramipexole dihydrochloride 0.5 mg tablets blister pack

Country: Ástralía

Tungumál: enska

Heimild: Department of Health (Therapeutic Goods Administration)

Virkt innihaldsefni:

pramipexole dihydrochloride monohydrate, Quantity: 0.5 mg

Fáanlegur frá:

Arrotex Pharmaceuticals Pty Ltd

INN (Alþjóðlegt nafn):

pramipexole dihydrochloride monohydrate

Lyfjaform:

Tablet, uncoated

Samsetning:

Excipient Ingredients: silicon dioxide; povidone; pregelatinised maize starch; magnesium stearate; mannitol

Stjórnsýsluleið:

Oral

Einingar í pakka:

10, 30, 100

Gerð lyfseðils:

(S4) Prescription Only Medicine

Ábendingar:

Pramipexole tablets are indicated for:,-the treatment of signs and symptoms of idiopathic Parkinson's disease. It may be used as monotherapy or in combination with levodopa.,-the symptomatic treatment of primary Restless Legs Syndrome.

Vörulýsing:

Visual Identification: White, oval, uncoated tablets debossed with 'CL' and '4' debossed on one side with breakline in between and a breakline on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Leyfisstaða:

Licence status A

Leyfisdagur:

2014-09-23